350 related articles for article (PubMed ID: 35784306)
1. Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response.
Cai Y; Li K; Lin J; Liang X; Xu W; Zhan Z; Xue S; Zeng Y; Chai P; Mao Y; Song Z; Han L; Song Y; Zhang X; Wang H
Front Immunol; 2022; 13():910490. PubMed ID: 35784306
[TBL] [Abstract][Full Text] [Related]
2. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
[TBL] [Abstract][Full Text] [Related]
3. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma.
Fan T; Wan Y; Niu D; Wang B; Zhang B; Zhang Z; Zhang Y; Gong Z; Zhang L
Discov Oncol; 2022 Mar; 13(1):13. PubMed ID: 35274175
[TBL] [Abstract][Full Text] [Related]
5. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis in glioma: Current management and future application.
Guo Z; Su Z; Wei Y; Zhang X; Hong X
Immunol Rev; 2024 Jan; 321(1):152-168. PubMed ID: 38063042
[TBL] [Abstract][Full Text] [Related]
7. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma.
Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T
Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554
[TBL] [Abstract][Full Text] [Related]
8. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
Chen J; Chen S; Li B; Zhou S; Lin H
Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
[TBL] [Abstract][Full Text] [Related]
9. Pyroptosis: A road to next-generation cancer immunotherapy.
Fang Y; Tang Y; Huang B
Semin Immunol; 2023 Jul; 68():101782. PubMed ID: 37302166
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.
Wu J; Zhu Y; Luo M; Li L
Front Immunol; 2021; 12():748221. PubMed ID: 34659246
[TBL] [Abstract][Full Text] [Related]
11. Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma.
Chen W; He Y; Zhou G; Chen X; Ye Y; Zhang G; Liu H
BMC Med; 2024 Jan; 22(1):24. PubMed ID: 38229080
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes identified by pyroptosis-related genes are associated with tumor microenvironment cell infiltration in colon cancer.
Ling Y; Wang Y; Cao C; Feng L; Zhang B; Li S
Aging (Albany NY); 2022 Nov; 14(22):9020-9036. PubMed ID: 36384889
[TBL] [Abstract][Full Text] [Related]
13. Gasdermins and cancers.
Hou J; Li T; Hsu JM; Zhang X; Hung MC
Semin Immunol; 2023 Nov; 70():101833. PubMed ID: 37647772
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer.
Zeng X; Huang X; Yin L; Yu H; Wang S; Li L
Cancer Genet; 2023 Aug; 276-277():60-69. PubMed ID: 37506530
[TBL] [Abstract][Full Text] [Related]
15. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
Front Immunol; 2021; 12():691811. PubMed ID: 34489938
[TBL] [Abstract][Full Text] [Related]
16. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
Sun L; Wang J; Li Y; Kang Y; Jiang Y; Zhang J; Qian S; Xu F
BMC Cancer; 2024 May; 24(1):567. PubMed ID: 38711020
[TBL] [Abstract][Full Text] [Related]
17. CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment.
Guo K; Zhao J; Jin Q; Yan H; Shi Y; Zhao Z
Front Oncol; 2022; 12():818283. PubMed ID: 36119521
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the Role of Pyroptosis in Lower-Grade Glioma: Development of a Novel Scoring System to Enhance Personalized Therapeutic Approaches.
Chen X; Xu Y; Wang M; Ren C
J Mol Neurosci; 2023 Aug; 73(7-8):649-663. PubMed ID: 37566191
[TBL] [Abstract][Full Text] [Related]
19. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.
Peng M
Front Immunol; 2022; 13():970885. PubMed ID: 36003383
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma.
Jiang A; Meng J; Bao Y; Wang A; Gong W; Gan X; Wang J; Bao Y; Wu Z; Lu J; Liu B; Wang L
Front Oncol; 2021; 11():755212. PubMed ID: 34804944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
